INDEX PHARM. AB AK B O.N.
InDex Pharmaceuticals Holding AB (publ) engages in the research and development of pharmaceuticals for immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.
Market Cap & Net Worth: INDEX PHARM. AB AK B O.N. (1NP)
INDEX PHARM. AB AK B O.N. (F:1NP) has a market capitalization of $238.80 Million (€232.64 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #12405 globally and #1322 in its home market, demonstrating a -25.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INDEX PHARM. AB AK B O.N.'s stock price €2.98 by its total outstanding shares 78066400 (78.07 Million).
INDEX PHARM. AB AK B O.N. Market Cap History: 2020 to 2026
INDEX PHARM. AB AK B O.N.'s market capitalization history from 2020 to 2026. Data shows change from $1.39 Billion to $238.80 Million (-33.34% CAGR).
INDEX PHARM. AB AK B O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INDEX PHARM. AB AK B O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1NP by Market Capitalization
Companies near INDEX PHARM. AB AK B O.N. in the global market cap rankings as of March 19, 2026.
Key companies related to INDEX PHARM. AB AK B O.N. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
INDEX PHARM. AB AK B O.N. Historical Marketcap From 2020 to 2026
Between 2020 and today, INDEX PHARM. AB AK B O.N.'s market cap moved from $1.39 Billion to $ 238.80 Million, with a yearly change of -33.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €238.80 Million | -24.46% |
| 2025 | €316.12 Million | +0.13% |
| 2024 | €315.72 Million | +994.44% |
| 2023 | €28.85 Million | -94.18% |
| 2022 | €496.02 Million | -61.36% |
| 2021 | €1.28 Billion | -7.97% |
| 2020 | €1.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of INDEX PHARM. AB AK B O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $238.80 Million USD |
| MoneyControl | $238.80 Million USD |
| MarketWatch | $238.80 Million USD |
| marketcap.company | $238.80 Million USD |
| Reuters | $238.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.